Abstract
To investigate diffusion-weighted magnetic resonance imaging (DWI) as an early and reproducible response indicator in women receiving concurrent radiotherapy and chemotherapy (chemoradiation) for advanced cervical cancer.
Original language | English |
---|---|
Pages (from-to) | 213-20 |
Number of pages | 8 |
Journal | Gynecologic Oncology |
Volume | 111 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2008 |